Feb 13, 2026 3-5pm ET
Friday on The Robert Scott Bell Show:
Hour 1
MAHA Offers Midterm Gift to GOP MAHA Action President Tony Lyons sent a memo dated February 11, 2026, to RNC Chairman Joe Gruters, NRSC Chairman Tim Scott, and NRCC Chairman Richard Hudson, describing the Make America Healthy Again (MAHA) movement as a once-in-a-generation political gift to the Republican Party that could expand its voter base and secure victories in upcoming elections, including the 2026 midterms. Lyons urged Republican leaders to actively embrace and demonstrate support for MAHA principles, emphasizing that every Republican candidate and officeholder must adopt the agenda to capitalize on its potential, mirroring President Trump’s endorsement. The memo, which copied Senate Majority Leader John Thune and Speaker Mike Johnson, outlined five core policy goals articulated by Robert F. Kennedy Jr.: promoting real, whole foods over ultra-processed products, making healthy living more affordable and accessible, removing toxins from the food supply, limiting pesticide use in agriculture, and addressing overmedicalization and excessive pharmaceutical interventions in children. Lyons argued that championing these issues would resonate strongly with undecided voters, independents, and even some Democrats concerned about chronic disease, environmental health, and corporate influence in food and medicine, positioning Republicans to capture a broad coalition focused on wellness and prevention. He highlighted MAHA’s organizational strength through the affiliated MAHA PAC, which has already endorsed GOP candidates such as Rep. Julia Letlow in her primary challenge against incumbent Sen. Bill Cassidy, following Trump’s lead in supporting challengers aligned with the movement. Lyons stated the PAC would exclusively back Republican candidates due to party-line dynamics on key health-related votes and offered resources including education, talking points, endorsements, advertising support, mailings, emails, and text campaigns to help hesitant Republicans integrate MAHA messaging. The memo was republished by POLITICO, which interpreted it as a subtle warning that failure to prioritize MAHA could risk alienating its supporters and fracturing the 2024 Trump-Kennedy coalition that contributed to electoral success. Lyons clarified his intent as presenting an opportunity rather than a threat, expressing openness to dialogue and collaboration to ensure widespread adoption. Reader responses on the platform showed strong grassroots enthusiasm, with comments from Texas expressing willingness to replace Gov. Greg Abbott if he did not align with MAHA, and others calling for Sen. Cassidy’s retirement due to perceived ties to pharmaceutical interests compromising his independence on health policy matters. The piece frames MAHA as a potent electoral asset for Republicans if leveraged effectively in midterm campaigns.
Special Guest: Dr. Stephen Sanders
Dr. B. Stephen Sanders is a board-certified family medicine physician and founder of Whole Men’s Health, dedicated to helping men restore strength, energy, and purpose in a world that quietly erodes all three.
In his late 30s, despite being a physician, Dr. Sanders found himself exhausted, burned out, and disconnected from the man he knew he was capable of being. He refused to accept decline as “normal.” By rebuilding his own health through hormone optimization, disciplined training, nutrition, and lifestyle redesign, he experienced firsthand what most men are never taught: vitality, clarity, and drive can be rebuilt.
That personal transformation became his mission.
As a husband and father of three sons and a daughter, Dr. Sanders is driven by a commitment to model strength, discipline, and presence for the next generation. His work is rooted in the belief that when men take responsibility for their health, they become better husbands, fathers, leaders, and contributors to their communities.
With over 15 years of clinical leadership, Dr. Sanders now leads a nationwide team delivering personalized, evidence-based men’s health care. He lives the high-performance lifestyle he teaches and empowers men to reclaim ownership of their bodies, their energy, and the lives they’re meant to lead.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we highlight Alfalfa — Medicago sativa, California Clover or Lucerne.
Boericke describes this remedy as acting upon the sympathetic nervous system, favorably influencing nutrition, appetite, digestion, and overall vitality. It is especially useful in conditions marked by malnutrition, nervous exhaustion, tissue waste, and debility, often producing weight gain and improved physical and mental vigor.
Download the Information Sheet
Hour 2
Vaccine Manufacturers Put on Dramatic Notice: FDA Rejects Moderna’s Flu Vaccine Application The FDA issued a refusal-to-file letter rejecting Moderna’s biologics license application for its mRNA-based influenza vaccine mRNA-1010, citing the Phase 3 trial design’s failure to meet the “adequate and well-controlled” standard under 21 CFR 314.126, as the comparator vaccine—a standard-dose quadrivalent influenza vaccine from GlaxoSmithKline—was not the best available therapy for adults aged 65 and older, where ACIP preferentially recommends high-dose, adjuvanted, or recombinant vaccines to reduce severe outcomes in this high-risk group. Moderna’s trial P304 enrolled over 43,000 participants aged 50 and above and showed a statistically significant 26.6% relative efficacy improvement over the standard comparator for PCR-confirmed influenza illness, meeting primary endpoints and aligning with historical approvals such as Fluzone High-Dose’s 24% efficacy gain and Flublok’s 30% improvement in similar populations, yet the FDA determined this comparator inflated apparent benefits by not reflecting current standard of care for seniors. In a separate immunogenicity study P303 Part C focused on adults 65 and older, mRNA-1010 was compared only against a high-dose vaccine without accompanying efficacy data, leaving insufficient evidence of superiority or non-inferiority in the key demographic. FDA communications from April 2024 had indicated the standard-dose comparator was acceptable but strongly recommended using a high-dose or enhanced vaccine for participants over 65 to better inform future ACIP recommendations, with a request that informed consent forms acknowledge the choice if standard-dose was retained; Moderna did not fully adopt this guidance, contributing to the rejection. The decision was signed by CBER Director Vinayak Prasad, who referenced a November 2025 internal memo criticizing low-quality evidence in prior flu vaccine approvals and rejecting reliance on surrogate endpoints like antibody titers alone. Moderna CEO Stéphane Bancel described the rejection as raising no safety or efficacy concerns, following prior FDA discussions, and as hindering U.S. innovation, while publicly releasing the letter; the company provided additional analyses in its application but did not include direct efficacy comparisons against preferred vaccines in seniors. This occurred under shifting regulatory leadership, including Prasad’s influence and broader policy changes under the current administration, such as rolling back routine childhood immunization recommendations for influenza and other diseases while emphasizing risk stratification and higher evidentiary standards for vaccines comparable to drugs. Internationally, regulators in Europe, Canada, and Australia accepted Moderna’s application for review without raising the comparator issue. The rejection underscores heightened scrutiny of trial design rigor for vaccine approvals, with implications for future mRNA flu vaccine development in the U.S., as Moderna indicated reluctance to pursue additional trials due to perceived barriers, potentially delaying progress in seasonal influenza prevention amid ongoing debates over evidentiary requirements and innovation incentives in vaccine technology.Special Guests: Dr. Robert Thompson and Mary Stenger
Born with profound hearing loss, Dr. Robert Thompson, MD, learned to observe what others overlooked. Free from the noise of conventional thinking, he saw patterns in cellular health that medicine had missed for decades. His discoveries have helped thousands across 38 countries reclaim their health when nothing else worked.
Learn more at aurorahealthandnutrition.com.
Dr. Mary Kay Stenger, PhD, RN, CHT, immediately recognized the significance of Dr. Thompson’s groundbreaking discoveries as the bottom line to our health and healing. She dedicated herself to translating the complex medical science into a format physicians and patients would benefit from. She brings experience from critical care nursing, creating health education programs, and integrative medicine into her work, specializing in hypnotherapy for trauma and complex medical issues.
Learn more at www.naturalhealthybalance.com
Oklahoma’s ‘Medical Freedom Act’ Would Block Mandates in Schools, Workplaces, Public Buildings, and Businesses Oklahoma Senate Bill 1560, titled the Oklahoma Medical Freedom Act and introduced in the Second Session of the 60th Legislature by Senator Randy Grellner (R-District 21), would prohibit businesses, schools, ticket issuers, entertainment venues, and state or local governments from requiring any medical intervention as a condition of employment, access to services, compensation, public benefits, entry into public spaces, or participation in events, defining “medical intervention” broadly to encompass medical procedures, treatments, devices, drug injections, medications, or actions intended to diagnose, prevent, cure disease, or alter health or biological function, thereby covering vaccines, injections, preventative treatments, and potential future biomedical technologies beyond just COVID-19 measures. The bill bars businesses from refusing service, products, venue admission, or transportation based on medical-intervention status, prohibits conditioning employment or offering differential pay, wages, compensation, or benefits on such status except where federal law mandates it or for foreign travel requirements, and prevents entertainment venues, promoters, sports leagues, and performers from denying access to events or performances on this basis, effectively blocking any revival of proof-of-vaccination or similar systems for concerts, sporting events, or gatherings. Public, private, and parochial schools—including universities and technology centers—are prohibited from mandating medical interventions for attendance, campus entry, or employment, subject to existing Oklahoma education statutes and applying across all levels of education. State and local governments, unless required by federal law, cannot condition government benefits, services, licenses, permits, entry into public buildings, public transportation, or public employment on medical-intervention status, closing off indirect mandate pathways through regulatory or licensing mechanisms. The legislation allows traditional personal protective equipment requirements rooted in long-standing industry standards but explicitly excludes vaccines, mask mandates, and other interventions introduced during the COVID-19 pandemic from qualifying under those exemptions, preventing reclassification of emergency measures as standard practice. A significant exemption preserves federal influence by excluding entities receiving Medicare or Medicaid funding from certain employment-related restrictions, enabling hospitals, clinics, and major healthcare employers tied to federal programs to potentially impose requirements linked to funding conditions in scenarios like a federally declared pandemic. Enforcement would occur through actions by the Attorney General or county district attorneys seeking injunctive relief, with violators liable for costs and reasonable attorney fees, and an emergency clause would render the law effective immediately upon passage and signature. The bill positions Oklahoma to structurally resist future public-health emergency directives at the state level, contrasting with recent federal actions like the $5.5 billion allocation in H.R. 7148 for pandemic preparedness and influenza countermeasures without an active emergency, amid broader nationwide efforts to prevent recurrence of pandemic-era mandates conditioning everyday activities on medical compliance, though the federal funding carve-out leaves a pathway for continued influence over federally supported institutions.Remember Friends, The Power to Heal is Yours!
